A Study of Patients With Relapsed/Refractory Mantle Cell Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting
Clinical trial NCT06788652 · RECRUITING
Trial details
- NCT number
- NCT06788652
- Sponsor
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-02-04
- Primary completion
- 2044-09-30
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.